Congo vs Greece: The number of people with susceptibility test result for rifampicin
Congo
42.71
in 2021
Greece
45.08
in 2021
Congo rank
122nd
Greece rank
119th
The number of people with susceptibility test result for rifampicin over time
- Congo
- Greece
How they compare
Greece currently reports 45.08 against 42.71 in Congo, a difference of 2.37.
That makes Greece's figure about 1.1 times Congo's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Greece ahead.
Congo ranks 122nd and Greece ranks 119th of 146 countries.
Across the 2 decades both report, Congo averaged higher in 1 and Greece in 1.
Head to head by decade
| Decade | Congo | Greece | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 15.4 | 55.64 | 40.24 | Greece |
| 2020s | 71.35 | 69.01 | 2.35 | Congo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Congo or Greece?
- Greece, at 45.08 against 42.71 in Congo as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Congo and Greece?
- 2.37, with Greece ahead.
- How many years of comparable data are there for Congo and Greece?
- 5 years are reported by both, from 2017 to 2021.
- How do Congo and Greece rank globally for the number of people with susceptibility test result for rifampicin?
- Congo ranks 122nd and Greece ranks 119th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.